Online education self-management programme in people with kidney disease

Conditions

Chronic kidney disease Urological and Genital Diseases Chronic kidney disease

Gurneet Kaur Sohansoha, Noemi Vadaszy, E Ford, Thomas J. Wilkinson, Matthew Graham-Brown et al. (7 authors)

PLOS Digital Health2026-02-20

10.1371/journal.pdig.0001166

The effects of a digital health intervention on patient activation in chronic kidney disease.

Lightfoot CJ, Wilkinson TJ, Sohansoha GK, Gillies CL, Vadaszy N, Ford EC, Davies MJ, Yates T, Smith AC, Graham-Brown MPM, SMILE-K collaborators.

2024-11-1211 citations

10.1038/s41746-024-01296-1

‘Self-Management Intervention through Lifestyle Education for Kidney health’ (the SMILE-K study): protocol for a single-blind longitudinal randomised controlled trial with nested pilot study

Courtney J. Lightfoot, Thomas J. Wilkinson, Thomas Yates, Melanie J. Davies, Alice C. Smith

BMJ Open2022-11-0116 citations

10.1136/bmjopen-2022-064916

Interventions

Patients will be randomised 2:1 into either an intervention group or usual care (control) group. The intervention group will have access to ‘My Kidneys & Me’ – an online self-management educational pr

Eligibility

Sex/Gender

All

Age

18 Years to 120 Years

Inclusion criteria

Inclusion criteria: 1. Individuals aged 18 years or older 2. Established CKD stage 3-4 (eGFR of 15-59 ml/min/1.73m²) according to the NICE guidelines

Exclusion criteria

Exclusion criteria: Those requiring any form of renal replacement therapy (i.e. any modality of dialysis, or transplantation) or with insufficient command of English or any other precluding factors that prevent ability to give informed consent or comply with protocol

Design outcomes

Primary

Measure	Time frame
Patient activation assessed using the Patient Activation Measure (PAM-13) at baseline, week 10, and week 20	—

Secondary

Measure	Time frame
Measured at baseline, week 10, and week 20: Part A: 1. Disease knowledge measured using the Chronic Kidney Disease Self-Management Knowledge Tool (CKD-SMKT) 2. Quality of life measured using the 12-Item Short-Form Health Survey (SF-12) 3. Symptoms measured using the Kidney Symptom Questionnaire (KSQ) 4. Sarcopenia measured using the SARC-F questionnaire 5. Illness perceptions measured using the Illness Representations Questionnaire (Brief) (IPQ-R) 6. Physical activity measured using the General Practice Physical Activity Questionnaire (GPPAQ) 7. Diet measured using the UK Diabetes and Diet Questionnaire (UKDDQ) 8. Medication adherence measured using the Medication Adherence Report Scale (MARS-5) 9. Healthcare usage measured using the Modified Economic Patient Questionnaire (EPQ) Part B 1. Anthropometry measured using height, weight, hip and waist circumference 2. Muscle phenotyping using B-mode ultrasonography and myotonometry 3. Gait speed measured using a 4m gait speed test 4. Handgrip strength (HGS) measured using a handheld dynamometer 5. Physical function measured using sit-to-stand-60 test 6. Physical function measured using timed-up-and-go test (TUAG) 7. Physical activity measured using accelerometery Part B2: Self-management knowledge, skills, confidence and behaviours, and attitudes towards lifestyle self-management, assessed using semi-structured interviews	—

Measure

Time frame

Measured at baseline, week 10, and week 20: Part A: 1. Disease knowledge measured using the Chronic Kidney Disease Self-Management Knowledge Tool (CKD-SMKT) 2. Quality of life measured using the 12-Item Short-Form Health Survey (SF-12) 3. Symptoms measured using the Kidney Symptom Questionnaire (KSQ) 4. Sarcopenia measured using the SARC-F questionnaire 5. Illness perceptions measured using the Illness Representations Questionnaire (Brief) (IPQ-R) 6. Physical activity measured using the General Practice Physical Activity Questionnaire (GPPAQ) 7. Diet measured using the UK Diabetes and Diet Questionnaire (UKDDQ) 8. Medication adherence measured using the Medication Adherence Report Scale (MARS-5) 9. Healthcare usage measured using the Modified Economic Patient Questionnaire (EPQ) Part B 1. Anthropometry measured using height, weight, hip and waist circumference 2. Muscle phenotyping using B-mode ultrasonography and myotonometry 3. Gait speed measured using a 4m gait speed test 4. Handgrip strength (HGS) measured using a handheld dynamometer 5. Physical function measured using sit-to-stand-60 test 6. Physical function measured using timed-up-and-go test (TUAG) 7. Physical activity measured using accelerometery Part B2: Self-management knowledge, skills, confidence and behaviours, and attitudes towards lifestyle self-management, assessed using semi-structured interviews

—

Countries

England, United Kingdom

Outcome results

None listed